Phase II trial of individualized lung tumor stereotactic ablative radiotherapy (iSABR) - Phase II trial of individualized lung tumor stereotactic ablative radiotherapy (iSABR)

Stanford Cancer Center 875 Blake Wilbur Drive Stanford, CA 943050 个研究点目标入组 217 人开始时间: 2015年10月13日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Evidence of uncontrolled extrathoracic metastases 2)Contraindication to receiving radiotherapy 3)Age < 18 years old. Children are excluded because lung malignancies rarely occur in this age group. Furthermore, treatment requires a great deal of patient cooperation including the ability to lie still for several hours in an isolated room. 4)Pregnant and breastfeeding women are excluded; as well as women of child-bearing potential who are unwilling or unable to use an acceptable method of birth control (hormonal or barrier method of birth control; abstinence) to avoid pregnancy for the duration of the study. Male subjects must also agree to use effective contraception for the same period as above. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately. 5)Prior radiation therapy is allowed but there should not be overlap with the prior high dose regions unless approved by the protocol directors.

发起方

Stanford Cancer Center 875 Blake Wilbur Drive Stanford, CA 94305